Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00600990 · ClinicalTrials.gov registry record · Phase 2
Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 624
- Enrollment target
NCT00600990: Completed Phase 2 study, sponsored by GlaxoSmithKline.
NCT00600990 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 624 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (369% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00600990, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 624 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of this medication in preventing nausea and vomiting in female patients at risk for post-operative nausea and vomiting (PONV).
Interventions
- DRUG GW597599
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 624 participants |
| Start Date | 2004-12 |
| Est. Completion | 2006-07 |
| Phase | Phase 2 |
What the finished NCT00600990 record still lists
NCT00600990 is an interventional study that assigns participants to a tested intervention. The registered 624 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (369% higher).
The record links to 0 conditions, and to 1 intervention - of which GW597599 is the first listed.
NCT00600990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00600990 about?
NCT00600990 is a clinical study titled "Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients". The purpose of this study is to determine the effectiveness of this medication in preventing nausea and vomiting in female patients at risk for post-operative nausea and vomiting (PONV).
What is the current status of trial NCT00600990?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 624 participants. The study started on 2004-12. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00600990?
The interventions under investigation include: GW597599 (DRUG).
Who is sponsoring clinical trial NCT00600990?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00600990's enrollment target sits among peer trials
624 52nd of 2000 higher than 1,949 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06406049 · 624 participants · NA
Finishing HIV Project
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia